A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

Mark Anderson, Michal Juraska, Nyaradzo Mgodi et al.|UNC Libraries|2023

Cited by 0